Home › Funds › Cypress Capital Group › ABBV

Cypress Capital Group position in ABBV

ABBVIE INC · Health Care

Cypress Capital Group reported holding 110,774 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$29.0M, representing 2.64% of its reported portfolio and ranking #5 among its reported holdings. Cypress Capital Group has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)110.77K sh
Reported value held$28.98M
Portfolio Weight2.64%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Cypress Capital Group's ABBV position evolved

Cypress Capital Group first disclosed a stake in ABBV in Q3 2023 at 111,982 shares (US$16.7M). The position peaked in Q3 2026 at 110,774 shares, worth US$29.0M. Across 13 filings, Cypress Capital Group increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 110,774 shares valued at US$29.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 111.98K $16.69M New
Q4 2023 110.92K $17.19M Reduce
Q1 2024 114.86K $20.92M Add
Q2 2024 113.93K $19.54M Reduce
Q3 2024 113.80K $22.47M Hold
Q4 2024 112.35K $19.96M Reduce
Q1 2025 107.59K $22.54M Reduce
Q2 2025 108.47K $20.13M Add
Q3 2025 107.95K $25.00M Hold
Q4 2025 112.61K $25.73M Add
Q1 2026 110.44K $24.02M Reduce
Q2 2026 111.03K $27.94M Add
Q3 2026 110.77K $28.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Cypress Capital Group held ABBV?

Cypress Capital Group has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cypress Capital Group's current position in ABBV?

As of Q3 2026, Cypress Capital Group holds 110.77K shares of ABBV (ABBVIE INC), valued at $28.98M, representing 2.64% of its reported portfolio and ranking #5.

Has Cypress Capital Group been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Cypress Capital Group held unchanged its position in ABBV. The position peaked in Q3 2026 at 110.77K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.